cardiopet
Small moleculeexperimentalImaging agent
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Sep 1, 2006 (NCT00413647)
Timeline
Indications
Studied for
Mechanism of action
- Unspecified targetRadiopharmaceutical
radiopharmaceutical
Chemistry & pharmacology
Loading structure…
SMILES
CCCCCCCCC([18F])CCCC[C@@H]1C[C@H]1CC(=O)O- Mol. weight
- 299.46 g/mol
- Lipinski Ro5
- 1 violation(s)
- Rule of 3
- No
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
- Imaging
- 18-fluorine
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL4594729 ↗
- ChEMBLCHEMBL4594398 ↗
Also known as
- cardiopet
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01826773 | Phase 2 | Mar 1, 2013 | FluoroPharma, Inc., Katholieke Universiteit Leuven |
| NCT00413647 | Phase 1 | Sep 1, 2006 | FluoroPharma, Inc., Harvard University |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| FluoroPharma, Inc. | For profit | 2 | 2 | 2 | 2006 |
| Harvard University | Academic/Hospital | 1 | 0 | 1 | 2006 |
| Katholieke Universiteit Leuven | Academic/Hospital | 1 | 0 | 1 | 2013 |
3 organizations
Page 1 / 1